The Cost of Generalized Anxiety Disorder in Primary Care Settings: Results of the ANCORA Study
- 8 April 2012
- journal article
- Published by Springer Nature in Community Mental Health Journal
- Vol. 48 (3) , 372-383
Abstract
To assess the cost of illness of generalized anxiety disorder (GAD) in a primary healthcare setting in Spain. A cross-sectional, retrospective study was conducted. The sample comprised patients diagnosed with GAD according to ICD-10 criteria and a control group. Healthcare/non-healthcare resource utilization was recorded retrospectively for the 12 months prior to the study visit. Costs were estimated from a societal perspective. Two models have been produced to study the variables that influence the cost of the illness both, without and with controls. The study enrolled 456 patients [76.8 % women, 49.2 (17.0) years] with GAD and 74 controls without GAD [42.5 % women, 47.9 (16.7) years]. 67.8 % of subjects were on combination therapy (antidepressant + anxiolytic); 6 % were using 2 or more drugs to treat anxiety; and 23.4 % were on monotherapy. Total annual average costs were higher in the GAD group (€7,739 vs. €2,609), with mean costs attributable to GAD of €5,139 (healthcare costs: €1,329, indirect costs: 75 % of total cost, approximately). Age and health status measured by Hamilton Anxiety Rating Scale and clinical global impression were related to costs. The improvements in quality of life measured by EQ-5D index are associated to lower cost. GAD treated in Spanish primary healthcare settings generated considerable healthcare costs and, particularly, loss-of-productivity costs.Keywords
This publication has 29 references indexed in Scilit:
- Service utilization and costs of first-onset schizophrenia in two widely differing health service areas in North-East SpainActa Psychiatrica Scandinavica, 2007
- Cost of affective disorders in EuropeEuropean Journal of Neurology, 2005
- Prevalence, Resource Utilization and Costs of Vascular Dementia Compared to Alzheimer’s Dementia in a Population SettingDementia and Geriatric Cognitive Disorders, 2005
- Prevalence of mental disorders in Europe: results from the European Study of the Epidemiology of Mental Disorders (ESEMeD) projectActa Psychiatrica Scandinavica, 2004
- Costes socioeconómicos de las enfermedades mentales en las Islas Canarias en 2002Atencion Primaria, 2004
- Medical and productivity costs of anxiety disorders: Case control studyDepression and Anxiety, 2004
- A framework for cost‐effectiveness analysis from clinical trial dataHealth Economics, 2001
- Markov Chain Monte Carlo in Practice.Journal of the American Statistical Association, 1997
- A new method of classifying prognostic comorbidity in longitudinal studies: Development and validationJournal of Chronic Diseases, 1987
- THE ASSESSMENT OF ANXIETY STATES BY RATINGPsychology and Psychotherapy: Theory, Research and Practice, 1959